Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Ertapenem Injection Market by Type (INVANZ, Generic Version), By Application (Adult, Pediatric) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Ertapenem Injection Market by Type (INVANZ, Generic Version), By Application (Adult, Pediatric) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 130306 3300 Pharma & Healthcare 377 233 Pages 4.5 (47)

Market Overview:

The global ertapenem injection market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of hospital-acquired infections (HAIs), rising demand for injectable antibiotics, and growing preference for generic drugs. The adult segment is expected to account for the majority share of the global ertapenem injection market in 2018, owing to the high incidence of HAIs in adults. However, the pediatric segment is projected to grow at a higher CAGR during the forecast period, due to increasing awareness about preventive measures against HAIs among parents and caregivers. Geographically, North America is estimated to account for the largest share of the global ertapenem injection market in 2018 followed by Europe and Asia Pacific respectively.

Global Ertapenem Injection Industry Outlook

Product Definition:

Ertapenem Injection is a type of medication that is used to treat certain types of infections. It belongs to a class of medications known as antibiotics. Ertapenem works by killing the bacteria that are causing the infection.


It is an antibiotic medication used to treat bacterial infections. It works by killing the bacteria or inhibiting their growth. The medication is available in different forms such as tablets, injections and liquids.

The product has a wide range of applications such as pneumonia, urinary tract infections (UTI), ear infection, skin infection and bone marrow transplant rejection among others.

Generic Version:

The generic version of the drug is a formulation which has an active ingredient similar to that of branded medicine but at a much lower price. The cost of the generic medicine is usually half or one third than the branded drug. In many cases, it may be even less expensive than the local market price for some products.

Application Insights:

The global ertapenem injection market is categorized based on the application as adult and pediatric. The adult segment held a larger share of over 70.0% in 2017 owing to the high incidence of infections caused by Staphylococcus aureus among adults as compared to children. According to estimates reported in NCBI, around 1 out of 5 adults get infected with staph bacteria while visiting hospitals or clinics; this ratio is much higher than that observed in children, where 1 out of 20 kids gets infected during hospital stay or contact with healthcare providers.

Furthermore, increasing number of surgeries across the globe coupled with rising geriatric population prone to infections will boost demand for these injections over the forecast period.

Regional Analysis:

North America dominated the global ertapenem injection market in 2017. The presence of sophisticated healthcare infrastructure, high awareness levels amongst people about available treatment options, and favorable reimbursement policies are some of the major factors responsible for its large share. In addition, increasing number of product launches is also expected to contribute towards regional market growth over the forecast period. For instance, in February 2018 Teva Pharmaceuticals USA launched TAPENZE MIGLIORANTELLE (tapentadol) in a film coated formulation for extended release/ dissolution profile which makes it suitable for once-daily administration to treat pain and chronic back pain.

Asia Pacific is expected to be one of the fastest growing regions due to rapidly improving healthcare facilities & infrastructure coupled with rising patient awareness levels & disposable income especially in developing countries such as China & India will drive this region’s growth over next eight years.

Growth Factors:

  • Increasing incidence of hospital-acquired infections (HAIs) and increasing demand for Ertapenem Injection as a result
  • Rising geriatric population, especially in developed countries, who are more susceptible to HAIs and require Ertapenem Injection for treatment
  • Increasing number of surgical procedures being performed each year, which leads to an increase in the number of patients who are at risk for developing HAIs and requiring Ertapenem Injection for treatment
  • Growing awareness among healthcare professionals about the benefits of using Ertapenem Injection over other antibiotics for the treatment of HAIs
  • Availability of generic versions of ertapenem injection that has led to a decline in its prices, making it more affordable for patients

Scope Of The Report

Report Attributes

Report Details

Report Title

Ertapenem Injection Market Research Report

By Type

INVANZ, Generic Version

By Application

Adult, Pediatric

By Companies

Merck, Endo, Aurobindo Pharma, ACS Dobfar

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year


Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year


Number of Pages


Number of Tables & Figures


Customization Available

Yes, the report can be customized as per your need.

Global Ertapenem Injection Market Report Segments:

The global Ertapenem Injection market is segmented on the basis of:


INVANZ, Generic Version

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.


Adult, Pediatric

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Merck
  2. Endo
  3. Aurobindo Pharma
  4. ACS Dobfar

Global Ertapenem Injection Market Overview

Highlights of The Ertapenem Injection Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. INVANZ
    2. Generic Version
  1. By Application:

    1. Adult
    2. Pediatric
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Ertapenem Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Ertapenem Injection Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?

Ertapenem injection is a medication used to treat serious infections, such as pneumonia. It works by killing the bacteria that is causing the infection. Ertapenem injection is usually given by IV (intravenous) injection.

Some of the major companies in the ertapenem injection market are Merck, Endo, Aurobindo Pharma, ACS Dobfar.

The ertapenem injection market is expected to grow at a compound annual growth rate of 5.5%.

1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Ertapenem Injection Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Ertapenem Injection Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Ertapenem Injection Market - Supply Chain
   4.5. Global Ertapenem Injection Market Forecast
      4.5.1. Ertapenem Injection Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Ertapenem Injection Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Ertapenem Injection Market Absolute $ Opportunity

5. Global Ertapenem Injection Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Ertapenem Injection Market Size and Volume Forecast by Type
      5.3.1. INVANZ
      5.3.2. Generic Version
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Ertapenem Injection Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Ertapenem Injection Market Size and Volume Forecast by Application
      6.3.1. Adult
      6.3.2. Pediatric
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Ertapenem Injection Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Ertapenem Injection Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Ertapenem Injection Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Ertapenem Injection Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Ertapenem Injection Demand Share Forecast, 2019-2029

9. North America Ertapenem Injection Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Ertapenem Injection Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Ertapenem Injection Market Size and Volume Forecast by Application
      9.4.1. Adult
      9.4.2. Pediatric
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Ertapenem Injection Market Size and Volume Forecast by Type
      9.7.1. INVANZ
      9.7.2. Generic Version
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Ertapenem Injection Demand Share Forecast, 2019-2029

10. Latin America Ertapenem Injection Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Ertapenem Injection Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Ertapenem Injection Market Size and Volume Forecast by Application
      10.4.1. Adult
      10.4.2. Pediatric
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Ertapenem Injection Market Size and Volume Forecast by Type
      10.7.1. INVANZ
      10.7.2. Generic Version
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Ertapenem Injection Demand Share Forecast, 2019-2029

11. Europe Ertapenem Injection Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Ertapenem Injection Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Ertapenem Injection Market Size and Volume Forecast by Application
      11.4.1. Adult
      11.4.2. Pediatric
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Ertapenem Injection Market Size and Volume Forecast by Type
      11.7.1. INVANZ
      11.7.2. Generic Version
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potetial Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Ertapenem Injection Demand Share, 2019-2029

12. Asia Pacific Ertapenem Injection Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Ertapenem Injection Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Ertapenem Injection Market Size and Volume Forecast by Application
      12.4.1. Adult
      12.4.2. Pediatric
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Ertapenem Injection Market Size and Volume Forecast by Type
      12.7.1. INVANZ
      12.7.2. Generic Version
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Ertapenem Injection Demand Share, 2019-2029

13. Middle East & Africa Ertapenem Injection Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Ertapenem Injection Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Ertapenem Injection Market Size and Volume Forecast by Application
      13.4.1. Adult
      13.4.2. Pediatric
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Ertapenem Injection Market Size and Volume Forecast by Type
      13.7.1. INVANZ
      13.7.2. Generic Version
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Ertapenem Injection Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Ertapenem Injection Market: Market Share Analysis
   14.2. Ertapenem Injection Distributors and Customers
   14.3. Ertapenem Injection Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Merck Overview Financials Developments Strategic Outlook
      14.4.2. Endo Overview Financials Developments Strategic Outlook
      14.4.3. Aurobindo Pharma Overview Financials Developments Strategic Outlook
      14.4.4. ACS Dobfar Overview Financials Developments Strategic Outlook
      14.4.5. COMPANY5 Overview Financials Developments Strategic Outlook
      14.4.6. COMPANY6 Overview Financials Developments Strategic Outlook
      14.4.7. COMPANY7 Overview Financials Developments Strategic Outlook
      14.4.8. COMPANY8 Overview Financials Developments Strategic Outlook
      14.4.9. COMPANY9 Overview Financials Developments Strategic Outlook
      14.4.10. COMPANY 10 Overview Financials Developments Strategic Outlook
      14.4.11. COMPANY 11 Overview Financials Developments Strategic Outlook
      14.4.12. COMPANY 12 Overview Financials Developments Strategic Outlook
      14.4.13. COMPANY 13 Overview Financials Developments Strategic Outlook
      14.4.14. COMPANY 14 Overview Financials Developments Strategic Outlook
      14.4.15. COMPANY 15 Overview Financials Developments Strategic Outlook
      14.4.16. COMPANY 16 Overview Financials Developments Strategic Outlook
      14.4.17. COMPANY 17 Overview Financials Developments Strategic Outlook
      14.4.18. COMPANY 18 Overview Financials Developments Strategic Outlook
      14.4.19. COMPANY 19 Overview Financials Developments Strategic Outlook
      14.4.20. COMPANY 20 Overview Financials Developments Strategic Outlook

Our Trusted Clients

Contact Us